Keywords: GlaxoSmithKline, Cervarix, Cervicalcancer, FDA, Approval

US FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine

Article | 19 October 2009

Print This

Following a recent favorable recommendation from an advisory committee, on October 16 the US Food and Drug Administration gave final approval ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in